Sunday, 16 May 2021 5:10 pmChums at the Mail on Sunday dug out a decent tale about top institutional shareholders backing GlaxoSmithKline in its running battle with American hedgie Elliott Management.
Monday, 09 December 2019 5:03 pmPaul Singer's Elliott Management started shaking the tree at Alexion last week, demaning a "proactive" sale of the $25 bilion US biopharmaceutical company.
